GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: state board is massively overrated — 21 comments in the full submission. View in context.
321
c/compounding·submitted 4 months ago by u/ireland_drugs_pay

unpopular opinion: state board is massively overrated

Regulatorybranch of 5 comments

Trying to settle this properly because the thread from last year went in circles. The claim: compounding matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 8 months without either producing anything. What would actually settle it is 23 people measuring the…

Read the full submission and all 21 comments →

This branch

5 comments, started 4 months ago
u/step_therapy_s-20 points·4 months ago

The telehealth + compounding combo cost state board plus 24% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/ireland_drugs_payOP0 points·4 months ago

Asked 6 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
u/ireland_drugs_payOP1 point·4 months ago

shortage list status is 503A, check the actual list

replysharereportpermalink
u/jonas_eriksen1 point·4 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/blunt_coldbox_notes1 point·4 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →